磁性纳米材料介导的癌症诊断和治疗
Xiaoli Liu1,2, Huan Zhang3, Tingbin Zhang3
1The College of Life Sciences, Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi'an, Shaanxi 710069, People's Republic of China.
Progress in biomedical engineering (Bristol, England)
|November 25, 2025
概括
磁铁氧化物纳米粒子 (MIONs) 由于其生物相容性和磁场响应性,在癌症诊断和治疗中表现有前途. 本综述涵盖了MIONs的合成,生物医学应用以及未来的研究方向.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 材料科学 材料科学 材料科学
背景情况:
- 磁性纳米材料,特别是磁性氧化铁纳米粒子 (MIONs),在生物医学领域获得了大量关注.
- 在合成单分散氧化铁纳米颗粒的突破加速了兴趣和应用.
- 当MION暴露于磁场时,它具有出色的生物相容性和独特的物理化学特性.
研究的目的:
- 从生物医学工程的角度提供磁性纳米材料的全面审查.
- 涵盖最近的合成方法,成像和治疗中的生物医学应用,以及生物安全评估.
- 讨论MION作为纳米平台的挑战和未来研究方向.
主要方法:
- 对磁性纳米材料的最新合成技术的审查.
- 分析MION在癌症诊断和治疗中的应用.
- 评估生物安全数据 (体外,体内和临床).
主要成果:
- 磁性纳米材料对于先进的生物医学应用具有多样性.
- 在各种治疗策略中,MIONs显示出潜力,包括治疗术,磁催化,向和磁热疗法.
- 生物安全和临床方面需要彻底评估才能有效实施.
结论:
- 磁性纳米材料,特别是MIONs,代表了一个有前途的纳米平台,用于综合癌症诊断和治疗.
- 需要进一步的研究来解决临床转化方面的挑战,并优化它们的治疗疗效.
- 跨学科的合作对于在临床实践中推进MIONs至关重要.
相关概念视频
Magnetic Resonance Imaging
9.0K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
9.0K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


